APA (7th ed.) Citation

Kübler, J., Kirschner, S., Hartmann, L., Welzel, G., Engelhardt, M., Herskind, C., . . . Giordano, F. A. (2016). The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo. OncoTarget, 7(29), . https://doi.org/10.18632/oncotarget.9787

Chicago Style (17th ed.) Citation

Kübler, Jens, et al. "The HIV-derived Protein Vpr 52-96 Has Anti-glioma Activity in Vitro and in Vivo." OncoTarget 7, no. 29 (2016). https://doi.org/10.18632/oncotarget.9787.

MLA (9th ed.) Citation

Kübler, Jens, et al. "The HIV-derived Protein Vpr 52-96 Has Anti-glioma Activity in Vitro and in Vivo." OncoTarget, vol. 7, no. 29, 2016, https://doi.org/10.18632/oncotarget.9787.